Biocon raises Rs 600 crore through commercial papers

23 Apr 2025 Evaluate

Biocon has raised Rs 600 crore through Commercial Papers (CPs) on private placement basis. Maturity of the said Commercial Papers will be on September 30, 2025. 

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. 

Biocon Share Price

377.45 9.10 (2.47%)
20-Mar-2026 13:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1773.40
Dr. Reddys Lab 1294.50
Cipla 1256.00
Zydus Lifesciences 889.70
Lupin 2318.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×